3 Dividend Stocks for May 2026
Why It Matters
These analyses help income‑focused investors allocate capital among high‑yield, dividend‑aristocrat, and growth‑oriented stocks, balancing yield, valuation discounts, and future payout sustainability.
Key Takeaways
- •Pfizer yields 6.6% but dividend growth stalled at 2.5% annualized.
- •Pfizer forecast modest dividend increase to $1.80 by 2029, trading 15% discount.
- •Sysco yields 3%, 56-year streak; Jetro debt may curb growth.
- •Watsco raised dividend 10% this quarter, 12‑year streak, 11.1% five‑year growth.
- •Watsco trades near fair value, prefers dividends over buybacks, cash‑flow covered.
Summary
Morningstar Dividend Investor editor David Harrell reviews three dividend‑heavy stocks—Pfizer, Sysco and Watsco—highlighting their yield, growth prospects and current valuation as of May 2026.
Pfizer trades at a 15% discount to a $32 fair‑value estimate, offering a 6.6% yield but only 2.5% annualized dividend growth and no increase in Q1 2026. Analysts project a modest rise to $1.80 by 2029. Sysco, the nation’s largest food‑service distributor, yields about 3% and boasts a 56‑year streak of dividend hikes, though its recent Jetro acquisition adds debt that could temper short‑term increases. Watsco, the top HVAC and refrigeration distributor, raised its payout 10% this quarter, maintaining a 12‑year consecutive increase record and an 11.1% five‑year growth rate.
Harrell cites the CFO’s comment that Sysco is “proud of our strong track record of dividend growth and dividend aristocrat status,” and notes Watsco’s preference for dividends over share repurchases, driven by insider family ownership. Despite beating earnings estimates, Watsco’s stock slipped 5% and now sits in three‑star territory.
For income investors, the three stocks present a trade‑off between high current yield and sustainable growth. Pfizer’s steep discount may appeal to value‑seeking investors willing to accept slower growth, Sysco offers stability but faces near‑term debt pressure, and Watsco combines solid cash‑flow coverage with a disciplined dividend policy, making it a compelling choice for those prioritizing payout reliability.
Comments
Want to join the conversation?
Loading comments...